Cart
sales@molnova.com
7β-O-Methylmorroniside
CAS No. 119943-46-3
7β-O-Methylmorroniside( ——— )
Catalog No. M38328 CAS No. 119943-46-3
7β-O-Methylmorroniside (7R-O-methylmorroniside) is a R-isomer of 7-O-Methyl morroniside.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 1581 | Get Quote |
|
| 25MG | Get Quote | Get Quote |
|
| 50MG | Get Quote | Get Quote |
|
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product Name7β-O-Methylmorroniside
-
NoteResearch use only, not for human use.
-
Brief Description7β-O-Methylmorroniside (7R-O-methylmorroniside) is a R-isomer of 7-O-Methyl morroniside.
-
Description7-O-Methylmorroniside exhibits anti-inflammatory activity.
-
In Vitro———
-
In Vivo———
-
Synonyms———
-
PathwayApoptosis
-
TargetTNF
-
RecptorTNF-α
-
Research Area———
-
Indication———
Chemical Information
-
CAS Number119943-46-3
-
Formula Weight420.411
-
Molecular FormulaC18H28O11
-
Purity>98% (HPLC)
-
Solubility———
-
SMILES———
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Liling Wang, et al. Simultaneous Determination of 11 High-Polarity Components from Fructus Corni: A Quantitative LC-MS/MS Method for Improved Quality Control. J Chromatogr Sci. 2018 Jan 1;56(1):56-64.?
molnova catalog
related products
-
Tebentafusp
Tebentafusp (IMCgp100) is a protein that specifically targets gp100 and consists of a soluble T-cell receptor functionally fused to an anti-CD3 immune effector Tebentafusp has potential anti-tumor activity, induces the production of inflammatory cytokines and cytolytic proteins, and can be used to study unresectable or metastatic uveal melanoma.
-
EJMC-1
EJMC-1 is an inhibitor of TNF-α with an IC50 value of 42 μM and can be used in studies about auto-inflammatory diseases.
-
Zigakibart
Zigakibart (BION-1301) is a humanized monoclonal antibody targeting TNFSF13 with anti-inflammatory activity for the study of immunoglobulin A nephropathy (IgAN).
